Nautilus Biotechnolgy, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$1.00
-1.29%
Mkt Cap $131.07M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
+150.8%
Consensus $2.50 vs current $1.00
NASDAQ·Healthcare·Biotechnology
$1.00
-1.29%
Mkt Cap $131.07M
Buy
1
Hold
0
Sell
0
Price Target (2 analysts)
$2.50
Range $2.50 – $2.50
+150.8%
Consensus $2.50 vs current $1.00